Retour
Prix Clover Biopharmaceuticals, Ltd. (02197.HK)
Graphique du cours de l'action 02197.HK
CLOVER BIO-B (02197.HK)
Clover Biopharmaceuticals, Ltd.
HK$2.46
-4.28%
$-0.1
Marché Régulier: Jan 20, 15:28:05 HKT
Pas encore de donnéesFollow-Up Questions
Quels sont les états financiers clés de Clover Biopharmaceuticals, Ltd. ?
Quels sont les ratios financiers clés pour 02197.HK ?
Comment les revenus de Clover Biopharmaceuticals, Ltd. sont-ils répartis par segment ou géographie ?
Clover Biopharmaceuticals, Ltd. est-elle rentable ?
Clover Biopharmaceuticals, Ltd. a-t-elle des passifs ?
Combien d'actions en circulation Clover Biopharmaceuticals, Ltd. a-t-elle ?
Statistiques clés
Clôture préc.
$2.57
Prix d'ouverture
$2.57
Plage de la journée
$2.45 - $2.57
Plage de 52 semaines
$0.185 - $3.18
Volume
5.5M
Volume moyen
10.9M
BPA (TTM)
-0.80
Rendement en dividend
--
Capitalisation boursière
$3.1B
Qu’est-ce que CLOVER BIO-B ?
Clover Biopharmaceuticals Ltd. engages in the research and development of biopharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 243 full-time employees. The company went IPO on 2021-11-05. The Company’s products and candidates include Respiratory Syncytial Virus (RSV) Vaccine (SCB-1019), seasonal quadrivalent influenza vaccine AdimFlu-S, SCB-219M, COVID-19 Vaccine and others. The firm leverages the Trimer-Tag technology platform to conduct research and development (R&D) for innovative vaccines that can fulfill unmet need, with a focus on building a respiratory vaccine franchise and establishing a presence in the pediatric vaccine market. The Trimer-Tag is a product development platform for the creation of protein-based vaccines based on naturally trimerization-dependent targets. The firm conducts its business in the domestic and overseas markets.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved